一项重大的2026年研究发现, Statins与糖尿病或认知下降之间没有重要联系,证实了其安全性和益处。 A major 2026 study finds statins do not increase diabetes or cognitive decline risk, confirming their safety and benefits.

2026年初公布的一项大规模研究发现,降低胆固醇的 Statin 胆固醇药物与糖尿病或认知下降风险增加之间没有重大联系,有效地消除了长期以来对严重副作用的关切。 A large-scale study released in early 2026 finds no significant link between statin cholesterol-lowering drugs and increased risk of diabetes or cognitive decline, effectively dispelling long-standing concerns about serious side effects. 研究人员分析了来自多个国家100 000多名病人的数据,得出的结论是,统计所在预防心脏病发作和中风方面的益处远远大于任何潜在风险。 Researchers analyzed data from over 100,000 patients across multiple countries, concluding that the benefits of statins in preventing heart attacks and strokes far outweigh any potential risks. 预计调查结果将影响医疗指导方针,并使数百万依赖这些药物的美国人放心。 The findings are expected to influence medical guidelines and reassure millions of Americans relying on these medications.